Needham & Company LLC Reaffirms Buy Rating for Celsius (NASDAQ:CELH)

Celsius (NASDAQ:CELH)‘s stock had its “buy” rating reiterated by analysts at Needham & Company LLC in a research report issued on Thursday, MarketBeat.com reports. They presently have a $60.00 target price on the stock, up from their prior target price of $55.00. Needham & Company LLC’s target price suggests a potential upside of 15.50% from the company’s current price.

A number of other analysts also recently issued reports on CELH. TD Cowen raised Celsius from a “hold” rating to a “buy” rating and lifted their target price for the company from $37.00 to $55.00 in a research report on Monday, June 16th. UBS Group lifted their price target on Celsius from $49.00 to $57.00 and gave the stock a “buy” rating in a report on Thursday, July 17th. Wall Street Zen upgraded Celsius from a “sell” rating to a “hold” rating in a report on Sunday, July 13th. Wells Fargo & Company lifted their price target on shares of Celsius from $44.00 to $45.00 and gave the company an “overweight” rating in a research report on Wednesday, June 4th. Finally, Roth Capital restated a “buy” rating and set a $52.00 price objective (up from $46.00) on shares of Celsius in a research report on Thursday, June 26th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $51.72.

Celsius Stock Up 3.7%

NASDAQ:CELH opened at $51.95 on Thursday. Celsius has a 12-month low of $21.10 and a 12-month high of $53.85. The company has a quick ratio of 3.04, a current ratio of 2.11 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $13.39 billion, a P/E ratio of 140.41, a P/E/G ratio of 1.81 and a beta of 1.40. The stock’s fifty day simple moving average is $44.51 and its 200-day simple moving average is $36.13.

Celsius (NASDAQ:CELH) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%. The business had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. During the same quarter last year, the business posted $0.28 EPS. The firm’s revenue was up 83.9% compared to the same quarter last year. Equities research analysts expect that Celsius will post 0.89 earnings per share for the current year.

Insider Buying and Selling

In related news, major shareholder William H. Milmoe sold 100,000 shares of the business’s stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $47.50, for a total value of $4,750,000.00. Following the sale, the insider owned 17,717,770 shares of the company’s stock, valued at $841,594,075. The trade was a 0.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO John Fieldly sold 143,167 shares of the business’s stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the completion of the sale, the chief executive officer directly owned 895,410 shares in the company, valued at approximately $45,827,083.80. This represents a 13.78% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,106,141 shares of company stock valued at $51,985,705 over the last 90 days. 2.55% of the stock is owned by insiders.

Institutional Trading of Celsius

A number of institutional investors have recently bought and sold shares of CELH. Alliancebernstein L.P. boosted its position in Celsius by 26.3% during the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock valued at $642,769,000 after acquiring an additional 3,753,055 shares during the last quarter. Champlain Investment Partners LLC bought a new stake in Celsius during the fourth quarter valued at $85,068,000. Alyeska Investment Group L.P. boosted its position in Celsius by 60.5% during the fourth quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company’s stock valued at $181,164,000 after acquiring an additional 2,591,345 shares during the last quarter. FMR LLC boosted its position in Celsius by 64.2% during the fourth quarter. FMR LLC now owns 4,055,148 shares of the company’s stock valued at $106,813,000 after acquiring an additional 1,585,839 shares during the last quarter. Finally, AQR Capital Management LLC bought a new stake in Celsius during the first quarter valued at $39,412,000. Institutional investors own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.